IGL Spirits H1 FY27 Revenue Rises 14.3% to ₹4,837 Crore
Key highlights
- IGL Spirits reported H1 FY27 revenue of ₹4,837.30 crore, up 14.3% year on year.
- H1 FY27 profit after tax rose 7.5% to ₹120.79 crore from ₹112.40 crore.
- Q2 FY27 revenue increased 10.3% to ₹2,295.41 crore, while EBITDA was ₹124.68 crore.
- The demerger scheme became effective on September 1, 2026, with an appointed date of April 1, 2026.
powered by IRIS

IGL Spirits Limited reported H1 FY27 revenue from operations of ₹4,837.30 crore, up 14.3% year on year, while profit after tax rose 7.5% to ₹120.79 crore in its first comparative results after the demerger from India Glycols Limited. The results cover the half year ended September 30, 2026.
Know IGL Spirits inside out
Results, valuation, peers and who's buying, in one view.
What did IGL Spirits report for Q2 and H1 FY27?
IGL Spirits reported revenue from operations of ₹2,295.41 crore for Q2 FY27, a 10.3% increase from ₹2,080.63 crore in Q2 FY26. Profit after tax rose 6.3% to ₹61.20 crore from ₹57.56 crore a year earlier. EBITDA was largely unchanged at ₹124.68 crore, compared with ₹124.59 crore in the corresponding quarter.
For H1 FY27, revenue from operations increased to ₹4,837.30 crore from ₹4,233.26 crore in H1 FY26. EBITDA rose 2.6% to ₹244.78 crore, while profit after tax increased from ₹112.40 crore to ₹120.79 crore. Half-year earnings per share improved to ₹18.02 from ₹16.77.
Why are these IGL Spirits' first post-demerger results?
These are IGL Spirits' first unaudited quarterly and half-yearly financial results following the separation of the spirits and biofuel undertaking from India Glycols. The business was transferred to IGL Spirits under a scheme of arrangement, allowing the company to report the financial performance of the separated undertaking independently.
The National Company Law Tribunal approved the scheme on July 17, 2026. The order was filed with the Registrar of Companies on September 1, 2026, when the scheme became effective. However, the appointed date for the transfer of the spirits and biofuel undertaking was April 1, 2026, meaning the reported financial statements reflect the accounting effects of the arrangement from that date.
How did the demerger separate India Glycols' businesses?
The demerger split India Glycols' businesses into separate entities. IGL Spirits received the spirits and biofuel undertaking, while the biopharma undertaking was transferred to Ennature Bio Pharma Limited. Both resulting companies are separately listed, according to the disclosures provided with the financial results.
India Glycols retained its continuing operations in biobased specialty materials, sustainable and performance chemicals, and gases. Therefore, India Glycols' Q2 FY27 results do not include the financial performance of the spirits, biofuel, or biopharma undertakings. This separation is important when comparing reported figures across the entities after the appointed date.
Got a follow-up? Ask IRIS
What do the FY27 numbers show about operating performance?
The FY27 numbers show that revenue grew faster than EBITDA and profit in both the quarter and the first half. In Q2, revenue grew 10.3%, whereas EBITDA increased by only 0.1% and profit after tax rose 6.3%. Based on the reported numbers, Q2 EBITDA margin was about 5.4%.
The H1 pattern was similar. Revenue expanded 14.3%, while EBITDA rose 2.6% and profit after tax increased about 7.5%. The company attributed the reported growth to a sharper focus on the spirits and biofuel businesses after the demerger. The disclosed figures do not provide a segment-wise breakup, volume data, or specific reasons for the difference between revenue and EBITDA growth.
How does the result matter to investors and the industry?
For investors, the results establish the first reported financial base for IGL Spirits as a separately listed company. The Q2 and H1 comparisons provide year-on-year data for revenue, EBITDA and profit after tax, but they should be read alongside the accounting and structural changes created by the scheme of arrangement.
The result also separates the performance of the spirits and biofuel undertaking from India Glycols' chemicals-focused continuing operations. No share-price movement, management guidance, dividend decision, capacity plan, or forward financial target was disclosed in the provided information. As a result, the reported earnings offer an initial operational reference point rather than evidence of any stated future outcome.
Conclusion
IGL Spirits began its post-demerger reporting with H1 FY27 revenue of ₹4,837.30 crore and profit after tax of ₹120.79 crore. Revenue growth exceeded the rise in EBITDA and profit, while the corporate separation created distinct reported businesses for spirits and biofuels, biopharma, and India Glycols' continuing chemicals operations.
The next reported financial update will show whether the difference between revenue growth and EBITDA growth persists. Investors can also watch for any future disclosures from IGL Spirits on operating performance, business plans, or other matters following the effective date of the demerger.


